BOSTON SCIENTIFIC CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
BOSTON SCIENTIFIC CORPORATION (BSX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.23% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-02-18
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.23%, a 1.86% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.31%, a 152.05% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 1.71%, a 755.00% increase from fiscal 2021.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.20%, a 85.40% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|
| 2024-12-31 | 4.23% 10-K · filed 2025-02-18 |
| 2023-12-31 | 4.31% 10-K · filed 2025-02-18 |
| 2022-12-31 | 1.71% 10-K · filed 2025-02-18 |
| 2021-12-31 | 0.20% 10-K · filed 2024-02-20 |
| 2020-12-31 | 1.37% 10-K · filed 2023-02-23 |
| 2019-12-31 | 2.48% 10-K · filed 2022-02-23 |
| 2018-12-31 | 2.36% 10-K · filed 2021-02-23 |
| 2017-12-31 | 1.45% 10-K · filed 2020-02-25 |
| 2011-12-31 | 1.10% 10-K · filed 2012-02-17 |
| 2010-12-31 | 1.29% 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |